Premedication to Reduce Amivantamab Associated Infusion Related Reactions
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Eisai Inc.
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Henan Cancer Hospital
SWOG Cancer Research Network
Takeda
Rigshospitalet, Denmark
Brown University
Sanofi
Barbara Ann Karmanos Cancer Institute
Peking University First Hospital
SWOG Cancer Research Network
National Institutes of Health Clinical Center (CC)
Checkpoint Therapeutics, Inc.
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
National Institutes of Health Clinical Center (CC)
Montefiore Medical Center
Calithera Biosciences, Inc
Genprex, Inc.
AbbVie
Peking University First Hospital
Aalborg University Hospital
AbbVie
SWOG Cancer Research Network
Consorzio Oncotech
National Institutes of Health Clinical Center (CC)
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Eli Lilly and Company
University of Arizona
Peking University First Hospital
AbbVie
Amgen
Stanford University
Boehringer Ingelheim
Sun Yat-sen University
Zhejiang University
M.D. Anderson Cancer Center
GlaxoSmithKline
University of Kentucky
National Cancer Institute (NCI)
Wales Cancer Trials Unit
Eli Lilly and Company
Geriatric Oncology Consortium